Jackson Walker partner Leisa Talbert Peschel discussed the limitations public institutions face when it comes to medical patent litigation in an interview with Bloomberg Law.
“It is rarely a good idea for a university system to pursue patent litigation on its own because they will not be making a product, and it’s very expensive,” Peschel said.
Read the full story here.
